Mateusz Jacek Spalek
Overview
Explore the profile of Mateusz Jacek Spalek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borkowska A, Pienkowski A, Chmiel P, Skora T, Michalik R, Rutkowski P, et al.
Cancer Control
. 2025 Mar;
32:10732748251323730.
PMID: 40067816
BackgroundChordoma is a rare and aggressive primary bone sarcoma. En-block resection remains the primary treatment, but some patients are unable to undergo it due to the location and potential complications....
2.
Borkowska A, Chmiel P, Rutkowski P, Telejko M, Spalek M
Ther Adv Med Oncol
. 2025 Feb;
17:17588359251316189.
PMID: 39943943
Background: The evidence base for the management of oligoprogression in metastatic melanoma (MM) is limited. To our knowledge, this study presents the first analysis of the local benefit (LB) of...
3.
Szostakowski B, Morysinski T, Rutkowski P, Spalek M
Rep Pract Oncol Radiother
. 2025 Feb;
29(4):437-444.
PMID: 39895956
Background: Osteoblastoma (OB) is a rare benign bone tumor, mainly affecting adolescents and young adults. It's commonly found in the spine and long bones, with a male-to-female ratio of 2:1....
4.
Ziomek M, Placzke J, Urbanek K, Skora T, Rutkowski P, Spalek M
Ther Adv Med Oncol
. 2024 Nov;
16:17588359241297868.
PMID: 39552637
Ewing sarcoma is a rare malignant neoplasm that primarily affects bone in children. Extraskeletal location is less common, while intradural extramedullary Ewing sarcoma (IEES) in adults is a casuistic phenomenon....
5.
Roohani S, Mirwald M, Ehret F, Fink C, Konig L, Striefler J, et al.
Cancer Med
. 2024 Nov;
13(22):e70347.
PMID: 39545524
Purpose: This study describes oncological outcomes and investigates prognostic factors for patients with gliosarcomas (GSM). Methods: Histopathologically confirmed GSM patients who underwent treatment at five European institutions were retrospectively analyzed....
6.
Spalek M, Bochynska A, Borkowska A, Mroczkowski P, Szostakowski B
Chin Clin Oncol
. 2024 Jun;
13(4):49.
PMID: 38859603
Background And Objective: Oncology is increasingly adopting three-dimensional (3D) printing, a method of creating objects through additive manufacturing using various techniques and materials. This technology, divided into conventional 3D printing...
7.
Roohani S, Ehret F, Beck M, Veltsista D, Nadobny J, Zschaeck S, et al.
Int J Hyperthermia
. 2024 Apr;
41(1):2342348.
PMID: 38653548
Purpose: To analyze the current practice of regional hyperthermia (RHT) for soft tissue sarcoma (STS) at 12 European centers to provide an overview, find consensuses and identify controversies necessary for...
8.
Roohani S, Wiltink L, Kaul D, Spalek M, Haas R
Curr Treat Options Oncol
. 2024 Mar;
25(4):543-555.
PMID: 38478330
Neoadjuvant radiotherapy (RT) over 5-6 weeks with daily doses of 1.8-2.0 Gy to a total dose of 50-50.4 Gy is standard of care for localized high-grade soft tissue sarcomas (STS)...
9.
Veltsista P, Oberacker E, Ademaj A, Corradini S, Eckert F, Florcken A, et al.
Int J Hyperthermia
. 2023 Jul;
40(1):2236337.
PMID: 37468132
Background: The therapy of high-risk soft tissue sarcomas (STS) remains an interdisciplinary challenge. Regional hyperthermia (RHT) sparked interest as it has been shown to improve overall survival when added to...
10.